Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Julio Vallejos
Rodrigo Zoni
María Bangher
Silvina Villamandos
Angelina Bobadilla
Fabian Plano
Claudia Campias
Evangelina Chaparro Campias
Maria Fernanda Medina
Fernando Achinelli
Hector Andres Guglielmone
Jorge Ojeda
Diego Farizano Salazar
Gerardo Andino
Pablo Kawerin
Silvana Dellamea
Antonia Cristina Aquino
Victor Flores
Carolina N. Martemucci
Silvina Maria Martinez
Juan Emanuel Segovia
Paola Itati Reynoso
Noelia Carolina Sosa
Mariana Elizabeth Robledo
Joaquina Maria Guarrochena
Maria Mercedes Vernengo
Natalia Ruiz Diaz
Elba Meza
María Gabriela Aguirre
机构：
[1] Instituto de Cardiología de Corrientes,Hospital de Campaña
[2] Epidemiology. Ministerio de Salud Pública de la Provincia de Corrientes,undefined
[3] Ministerio de Salud Pública de la Provincia de Corrientes,undefined
[4] Ministerio de Salud Pública de Corrientes,undefined
[5] Ministerio de Salud Pública de la Provincia de Corrientes,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Bromhexine for Post-exposure COVID-19 Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Tolouian, Ramin
    Moradi, Omid
    Mulla, Zuber D.
    Ziaie, Shadi
    Haghighi, Mehrdad
    Esmaily, Hadi
    Amini, Hossein
    Hassanpour, Rezvan
    Poorheidar, Elham
    Kouchek, Mehran
    Manafi-Rasi, Alireza
    Sali, Shahnaz
    Abolghasemi, Sara
    Tehrani, Shabnam
    Tolouian, Audrey C.
    Zali, Alireza
    Sistanizad, Mohammad
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2022, 15 (08)
  • [22] A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
    Rossignol, Jean-Francois
    Bardin, Matthew C.
    Fulgencio, Jessica
    Mogelnicki, Dena
    Brechot, Christian
    ECLINICALMEDICINE, 2022, 45
  • [23] Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial
    Elshafie, Ahmed Hanei
    Elsawah, Hozaifa Khalil
    Hammad, Mohamed
    Sweed, Eman Mohamed
    Seif, Ahmed Salah
    Ghaffar, Muhammad Mostafa Abdel
    Goda, Feisal Mahmoud
    Mosalam, Esraa M.
    Abdallah, Mahmoud S.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (10) : 1341 - 1350
  • [24] Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial
    Shah, Muhammad Raza
    Fatima, Samreen
    Khan, Sehrosh Naz
    Ullah, Shafi
    Himani, Gulshan
    Wan, Kelvin
    Lin, Timothy
    Lau, Johnson Y. N.
    Liu, Qingquan
    Lam, Dennis S. C.
    FRONTIERS IN MEDICINE, 2022, 9
  • [25] Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial
    Asadi, Masoomeh
    Sayar, Sara
    Radmanesh, Esmat
    Naghshi, Sina
    Mousaviasl, Sajedeh
    Jelvay, Saeed
    Ebrahimzadeh, Mona
    Mohammadi, Asma
    Abbasi, Samaneh
    Mobarak, Sara
    Bitaraf, Saeid
    Zardehmehri, Fatemeh
    Cheldavi, Ali
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
  • [26] Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
    De Niet, Sophie
    Tremege, Mickael
    Coffiner, Monte
    Rousseau, Anne-Francoise
    Calmes, Doriane
    Frix, Anne-Noelle
    Gester, Fanny
    Delvaux, Muriel
    Dive, Anne-Francoise
    Guglielmi, Elora
    Henket, Monique
    Staderoli, Alicia
    Maesen, Didier
    Louis, Renaud
    Guiot, Julien
    Cavalier, Etienne
    NUTRIENTS, 2022, 14 (15)
  • [27] Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial
    Labro, Guylaine
    Tubach, Florence
    Belin, Lisa
    Dubost, Jean-Louis
    Osman, David
    Muller, Gregoire
    Quenot, Jean-Pierre
    Da Silva, Daniel
    Zarka, Jonathan
    Turpin, Matthieu
    Mayaux, Julien
    Lamer, Christian
    Doyen, Denis
    Chevrel, Guillaume
    Plantefeve, Gaetan
    Demeret, Sophie
    Piton, Gael
    Manzon, Cyril
    Ochin, Evelina
    Gaillard, Raphael
    Dautzenberg, Bertrand
    Baldacini, Mathieu
    Lebbah, Said
    Miyara, Makoto
    de Chambrun, Marc Pineton
    Amoura, Zahir
    Combes, Alain
    INTENSIVE CARE MEDICINE, 2022, 48 (07) : 876 - 887
  • [28] Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
    Xuedong An
    Bo Peng
    Xiaodong Huang
    Hongmei Jiang
    Zhang’e Xiong
    Hong Zhang
    Fengmei Lian
    Yuanming Ba
    Xiaolin Tong
    Chinese Medicine, 17
  • [29] Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial
    Guylaine Labro
    Florence Tubach
    Lisa Belin
    Jean-Louis Dubost
    David Osman
    Grégoire Muller
    Jean-Pierre Quenot
    Daniel Da Silva
    Jonathan Zarka
    Matthieu Turpin
    Julien Mayaux
    Christian Lamer
    Denis Doyen
    Guillaume Chevrel
    Gaétan Plantefeve
    Sophie Demeret
    Gaël Piton
    Cyril Manzon
    Evelina Ochin
    Raphael Gaillard
    Bertrand Dautzenberg
    Mathieu Baldacini
    Said Lebbah
    Makoto Miyara
    Marc Pineton de Chambrun
    Zahir Amoura
    Alain Combes
    Intensive Care Medicine, 2022, 48 : 876 - 887
  • [30] Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
    An, Xuedong
    Peng, Bo
    Huang, Xiaodong
    Jiang, Hongmei
    Xiong, Zhang'e
    Zhang, Hong
    Lian, Fengmei
    Ba, Yuanming
    Tong, Xiaolin
    CHINESE MEDICINE, 2022, 17 (01)
12345